Jianguo Xu Selected Research

Craniopharyngioma (Craniopharyngiomas)

1/2017	Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
12/2015	Aberrant membranous expression of β-catenin predicts poor prognosis in patients with craniopharyngioma.
9/2015	Endovascular Treatment for Fusiform Dilation of Internal Carotid Artery Following Craniopharyngioma Resection: A Case Illustration.
1/2014	Relative quantitative expression of hypoxia-inducible factor 1α messenger ribonucleic acid in recurrent craniopharyngiomas.
5/2013	All-trans retinoic acid inhibits craniopharyngioma cell growth: study on an explant cell model.
1/2013	Craniopharyngioma cell growth is promoted by growth hormone (GH) and is inhibited by tamoxifen: involvement of growth hormone receptor (GHR) and IGF-1 receptor (IGF-1R).
11/2012	Intracystic bleomycin for cystic craniopharyngiomas in children (abridged republication of cochrane systematic review).
9/2012	Expression and inhibition of ADAMDEC1 in craniopharyngioma cells.
3/2012	Establishment of primary cultures of craniopharyngioma cells.
6/2007	Expression of human MCM6 and DNA Topo II alpha in craniopharyngiomas and its correlation with recurrence of the tumor.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianguo Xu Research Topics

Disease

54	Neoplasms (Cancer) 01/2022 - 04/2002
19	Sepsis (Septicemia) 01/2022 - 01/2002
16	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2022 - 01/2013
15	Neuralgia (Stump Neuralgia) 01/2021 - 08/2003
15	Infections 01/2021 - 11/2005
12	Inflammation (Inflammations) 01/2021 - 08/2005
12	Lung Injury 01/2021 - 02/2005
12	Hyperalgesia 09/2014 - 01/2006
11	Glioblastoma (Glioblastoma Multiforme) 09/2022 - 08/2014
11	Glioma (Gliomas) 01/2022 - 09/2013
11	Craniopharyngioma (Craniopharyngiomas) 01/2017 - 01/2006
9	Brain Injuries (Brain Injury) 05/2022 - 06/2014
8	Wounds and Injuries (Trauma) 01/2021 - 08/2010
7	Brain Edema (Cerebral Edema) 01/2022 - 08/2010
7	Neuroinflammatory Diseases 01/2021 - 02/2007
7	Fibrosis (Cirrhosis) 01/2012 - 08/2005
6	Pain (Aches) 12/2021 - 01/2006
6	Necrosis 01/2020 - 04/2006
6	Neoplasm Metastasis (Metastasis) 04/2019 - 12/2010
5	Pneumonia (Pneumonitis) 07/2022 - 09/2006
5	Cerebral Hemorrhage 01/2021 - 08/2018
5	Acute Lung Injury 01/2021 - 02/2005
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 04/2019
4	Carcinogenesis 01/2022 - 10/2006
4	Stroke (Strokes) 10/2021 - 11/2016
4	Brain Ischemia (Cerebral Ischemia) 01/2017 - 12/2008
4	Weight Loss (Weight Reduction) 01/2016 - 08/2010
3	Epilepsy (Aura) 02/2022 - 09/2011
3	Central Serous Chorioretinopathy 01/2022 - 01/2021
3	Ischemia 10/2021 - 01/2006
3	Ischemic Stroke 10/2021 - 01/2018
3	Hypoxia (Hypoxemia) 10/2020 - 01/2014
3	Melanoma (Melanoma, Malignant) 04/2020 - 09/2009
3	Brain Neoplasms (Brain Tumor) 01/2020 - 02/2012
3	Septic Shock (Toxic Shock Syndrome) 01/2019 - 01/2013
3	Bronchiolitis 01/2017 - 12/2008
3	Bacillary Dysentery (Shigellosis) 07/2015 - 02/2010
3	Reperfusion Injury 02/2015 - 12/2008
3	Meningitis 03/2013 - 01/2009

Drug/Important Bio-Agent (IBA)

25	CytokinesIBA 01/2021 - 01/2002
24	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2002
16	NF-kappa B (NF-kB)IBA 08/2017 - 01/2005
11	Biomarkers (Surrogate Marker)IBA 06/2022 - 04/2014
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2002
10	MicroRNAs (MicroRNA)IBA 05/2022 - 07/2018
10	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2002
9	Messenger RNA (mRNA)IBA 06/2020 - 01/2002
8	Bleomycin (Blenoxane)FDA LinkGeneric 11/2012 - 08/2005
7	EnzymesIBA 01/2022 - 04/2006
7	Pharmaceutical PreparationsIBA 06/2019 - 09/2010
7	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 06/2007
6	AntigensIBA 01/2020 - 04/2002
6	Neuroprotective AgentsIBA 01/2016 - 01/2013
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 01/2006
5	Phosphotransferases (Kinase)IBA 01/2021 - 01/2014
5	salicylhydroxamic acid (SHAM)IBA 02/2015 - 01/2007
5	Interleukin-10 (Interleukin 10)IBA 08/2013 - 01/2006
4	CateninsIBA 05/2022 - 12/2015
4	VaccinesIBA 01/2021 - 02/2010
4	AntibodiesIBA 10/2020 - 11/2008
4	LuteolinIBA 06/2020 - 06/2014
4	Therapeutic UsesIBA 01/2020 - 08/2002
4	LipopolysaccharidesIBA 01/2020 - 01/2003
4	Biological ProductsIBA 10/2019 - 10/2006
4	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 07/2015 - 07/2014
4	HES 130-0.4IBA 08/2010 - 09/2006
4	Starch (Cornstarch)IBA 08/2010 - 01/2005
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2008 - 03/2006
4	Pentoxifylline (Trental)FDA LinkGeneric 02/2008 - 01/2006
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 08/2017
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2020
3	Nucleic AcidsIBA 12/2021 - 01/2016
3	Hyaluronic Acid (Hyaluronan)IBA 04/2021 - 12/2011
3	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2020
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2018
3	CreatinineIBA 01/2021 - 04/2002
3	Caspase 3 (Caspase-3)IBA 01/2021 - 06/2007
3	Peptides (Polypeptides)IBA 06/2019 - 04/2014
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 01/2006
3	fibrin fragment D (D-dimer)IBA 01/2019 - 01/2018
3	Mifepristone (RU 486)FDA Link 01/2019 - 09/2014
3	RNA (Ribonucleic Acid)IBA 12/2018 - 06/2012
3	metapristoneIBA 12/2017 - 09/2014
3	Fingolimod Hydrochloride (FTY720)FDA Link 01/2016 - 11/2014
3	MelatoninIBA 12/2015 - 08/2014
3	Mirtazapine (Rexer)FDA LinkGeneric 09/2013 - 03/2008
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2013 - 08/2007
3	Interleukin-12 (IL 12)IBA 02/2012 - 04/2002
3	Evans Blue (Blue, Evans)FDA Link 08/2010 - 04/2006
3	InterleukinsIBA 08/2010 - 02/2007

Therapy/Procedure

22	Therapeutics 12/2021 - 04/2002
9	Ligation 01/2020 - 01/2007
5	Drug Therapy (Chemotherapy) 01/2022 - 10/2016
5	Radiotherapy 01/2021 - 11/2012
5	Punctures 01/2020 - 01/2007
4	Aftercare (After-Treatment) 01/2021 - 08/2010
3	Laser Therapy (Surgery, Laser) 01/2022 - 01/2021
3	Craniotomy 12/2021 - 02/2012
3	Immunotherapy 08/2020 - 01/2020
3	Lung Transplantation 01/2017 - 12/2008